[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

FDA approves Rituxan to treat two rare disorders



Title: FDA approves Rituxan to treat two rare disorders

FDA approves Rituxan to treat two rare disorders
Tue, 19 Apr 2011 15:07:00 -0500

The U.S. Food and Drug Administration today approved Rituxan (rituximab), in combination with glucocorticoids (steroids), to treat patients with Wegener’s granulomatosis (WG) and microscopic polyangiitis (MPA), two rare disorders that cause blood vessel inflammation (vasculitis).


Manage your FDA Subscriptions:

U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420


[CDC News]     [NIH News]     [USDA News]     [Photo]     [Yosemite in Winter]     [Hot Springs Photos]     [Steve's Art]     [Camping in Yosemite]     [Yosemite Photos]     [PhotoForum]     [SB Lupus]     [STB]

Add to Google Powered by Linux